pharma · Cancer · PBLS
Parabilis Medicines
Drugabilis is a pharma organization headquartered in Villejust, FR. It trades on NYSE under ticker PBLS. Primary therapeutic focus areas include Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and
Villejust, FR HQ
2004 Founded
8 Employees
Public company Type
PBLS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Villejust, FR
- Founded
- 2004
- Employees
- 8
- Programs
- 1
- Drugs
- 0
- Patents
- 1
FOG-001
Phase 2 · small molecule · Cancer
FOG-001 for Cancer is a Phase 2 program (small_molecule) at Parabilis Medicines with 1 ClinicalTrials.gov record(s).
Internal code FOG-001-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Parabilis Medicines
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Cancer
- Status
- active
- Trials
- 1